Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Allosteric kidney-type glutaminase (GLS) inhibitors with a mercaptoethyl linker.
Journal: Bioorganic & medicinal chemistry
Published: April 24, 2020
Upregulation of the Glutaminase II Pathway Contributes to Glutamate Production upon Glutaminase 1 Inhibition in Pancreatic Cancer.
Journal: Proteomics
Published: April 03, 2019
Uncovering the Role of N-Acetyl-Aspartyl-Glutamate as a Glutamate Reservoir in Cancer.
Journal: Cell reports
Published: January 05, 2018
Discovery of 6-Diazo-5-oxo-l-norleucine (DON) Prodrugs with Enhanced CSF Delivery in Monkeys: A Potential Treatment for Glioblastoma.
Journal: Journal of medicinal chemistry
Published: August 26, 2016
Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 26, 2016
Showing 1-5 of 5
Last Updated: 09/26/2026